Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy
Abstract Tenofovir and entecavir are currently designated as the preferred oral antiviral drugs for chronic hepatitis B. However, only less than 40% of patients can achieve HBeAg seroconversion. We aim at investigating the role of intestinal microbiome in HBeAg seroconversion induced by oral antivir...
Guardado en:
Autores principales: | Yu-Li Zeng, Lei Qin, Wen-Jun Wei, Hong Cai, Xiao-Fang Yu, Wei Zhang, Xiao-Lu Wu, Xiao-Bin Liu, Wei-Ming Chen, Pan You, Mei-Zhu Hong, Yaming Liu, Xuan Dong, Ben-Chang Shia, Jian-Jun Niu, Jin-Shui Pan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/796538f2eed8453fb934db7155a76d2a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
por: Sarah Kadelka, et al.
Publicado: (2021) -
Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
por: Chen-Hsuan Wu, et al.
Publicado: (2017) -
Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
por: Gao F, et al.
Publicado: (2021) -
Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Yan-Wei Zhong, et al.
Publicado: (2021) -
Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
por: Chih-Chien Yao, et al.
Publicado: (2017)